المؤلفون: Mortensen REJ; National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital, Herlev, Denmark., Holmström MO; National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital, Herlev, Denmark.; Department of Immunology and Microbiology, Copenhagen University, Copenhagen, Denmark., Lisle TL; National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital, Herlev, Denmark., Hasselby JP; Department of Pathology, Rigshospitalet, Copenhagen, Denmark., Willemoe GL; Department of Pathology, Rigshospitalet, Copenhagen, Denmark., Met Ö; National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital, Herlev, Denmark., Marie Svane I; National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital, Herlev, Denmark., Johansen J; Department of Oncology, Herlev Hospital, Herlev, Denmark., Nielsen DL; Department of Oncology, Herlev Hospital, Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Chen IM; Department of Oncology, Herlev Hospital, Herlev, Denmark., Andersen MH; National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital, Herlev, Denmark Mads.Hald.Andersen@regionh.dk.; Department of Immunology and Microbiology, Copenhagen University, Copenhagen, Denmark.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Mar; Vol. 11 (3).

نوع المنشور: Clinical Trial, Phase II; Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines*/therapeutic use , Immune Checkpoint Inhibitors*/therapeutic use , Immunity, Cellular* , Pancreatic Neoplasms*/drug therapy , Pancreatic Neoplasms*/radiotherapy , T-Lymphocytes*/immunology, Epitopes ; Leukocytes, Mononuclear ; Transforming Growth Factor beta ; Tumor Microenvironment ; Vaccines, Subunit ; Humans ; Pancreatic Neoplasms

المؤلفون: Grauslund JH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Holmström MO; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Institute for Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Martinenaite E; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Research and Development, IO Biotech ApS, Copenhagen, Denmark., Lisle TL; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Glöckner HJ; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., El Fassi D; Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Klausen U; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Mortensen REJ; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Jørgensen N; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Kjær L; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Skov V; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Hasselbalch HC; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Andersen MH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Institute for Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.

المصدر: Frontiers in immunology [Front Immunol] 2023 Feb 23; Vol. 14, pp. 1117466. Date of Electronic Publication: 2023 Feb 23 (Print Publication: 2023).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy , Myeloproliferative Disorders*/genetics, Humans ; B7-H1 Antigen/metabolism ; Adjuvants, Immunologic ; Epitopes ; Peptides ; Vaccines, Subunit ; RNA, Messenger

المؤلفون: Mortensen REJ; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Holmström MO; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Institute for Immunology and Microbiology, Copenhagen University, Copenhagen, Denmark., Andersen MH; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. mads.hald.andersen@regionh.dk.; Institute for Immunology and Microbiology, Copenhagen University, Copenhagen, Denmark. mads.hald.andersen@regionh.dk.

المصدر: Cellular & molecular immunology [Cell Mol Immunol] 2021 Nov; Vol. 18 (11), pp. 2575-2577. Date of Electronic Publication: 2021 Sep 15.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Chinese Society of Immunology;; _b Nature Pub. Group Country of Publication: China NLM ID: 101242872 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-0226 (Electronic) Linking ISSN: 16727681 NLM ISO Abbreviation: Cell Mol Immunol Subsets: MEDLINE

مواضيع طبية MeSH: CD4-Positive T-Lymphocytes/*immunology , Cancer Vaccines/*immunology , Epitopes, T-Lymphocyte/*metabolism , Hematologic Neoplasms/*immunology , Immunotherapy, Adoptive/*methods , Myeloid Cells/*immunology , Transforming Growth Factor beta/*metabolism, Cells, Cultured ; Epitopes, T-Lymphocyte/genetics ; Epitopes, T-Lymphocyte/immunology ; Gene Expression Regulation ; Hematologic Neoplasms/therapy ; Humans ; Transforming Growth Factor beta/genetics ; Transforming Growth Factor beta/immunology

المؤلفون: Holmström MO; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark., Mortensen REJ; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark., Pavlidis AM; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark., Martinenaite E; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark.; IO Biotech ApS, Copenhagen, Denmark., Weis-Banke SE; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark., Aaboe-Jørgensen M; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark., Bendtsen SK; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark., Met Ö; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark., Pedersen AW; IO Biotech ApS, Copenhagen, Denmark., Donia M; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark., Svane IM; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark., Andersen MH; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark. mads.hald.andersen@regionh.dk.; Institute for Immunology and Microbiology, Copenhagen University, Copenhagen, Denmark. mads.hald.andersen@regionh.dk.

المصدر: Cellular & molecular immunology [Cell Mol Immunol] 2021 Feb; Vol. 18 (2), pp. 415-426. Date of Electronic Publication: 2021 Jan 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Chinese Society of Immunology;; _b Nature Pub. Group Country of Publication: China NLM ID: 101242872 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-0226 (Electronic) Linking ISSN: 16727681 NLM ISO Abbreviation: Cell Mol Immunol Subsets: MEDLINE

مواضيع طبية MeSH: CD4-Positive T-Lymphocytes/*immunology , CD8-Positive T-Lymphocytes/*immunology , Epitopes, T-Lymphocyte/*immunology , HLA-A2 Antigen/*immunology , Neoplasms/*immunology , T-Lymphocytes, Cytotoxic/*immunology , Transforming Growth Factor beta/*metabolism, Case-Control Studies ; Humans ; Neoplasms/metabolism ; Neoplasms/pathology ; Neoplasms/prevention & control ; Transforming Growth Factor beta/genetics

المؤلفون: Martinenaite E; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark., Mortensen REJ; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark., Hansen M; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark., Orebo Holmström M; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Munir Ahmad S; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark., Grønne Dahlager Jørgensen N; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark., Met Ö; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.; Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Donia M; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.; Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark., Svane IM; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.; Department of Oncology, Copenhagen University Hospital Herlev, Herlev, Denmark., Andersen MH; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.; Department of Hematology, Zealand University Hospital, Roskilde, Denmark.

المصدر: Oncoimmunology [Oncoimmunology] 2017 Dec 26; Vol. 7 (3), pp. e1404215. Date of Electronic Publication: 2017 Dec 26 (Print Publication: 2018).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE